We are live on ! Find out more
JAMONY

Jacob Asset Management of New York Portfolio holdings

AUM $70.9M
1-Year Est. Return 14.28%
This Fund
S&P 500
This Quarter Est. Return
-0.57%
1 Year Est. Return
+14.28%
3 Year Est. Return
+22.72%
5 Year Est. Return
10 Year Est. Return
AUM
$275M
AUM Growth
-$27.9M
Cap. Flow
-$14.8M
Cap. Flow %
-5.37%
Top 10 Hldgs %
44.13%
Holding
85
New
3
Increased
36
Reduced
26
Closed
6

Sector Composition

Rank Sector Weight
1 Technology 33.87%
2 Healthcare 27.65%
3 Communication Services 17.2%
4 Financials 6.95%
5 Industrials 5.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DKNG icon
26
DraftKings
DKNG
$12.7B
$3.33M 1.21%
69,113
-8,887
-11% -$471K
SCOR icon
27
Comscore
SCOR
$108M
$3.12M 1.13%
40,000
+30,000
+300% +$2.38M
GOOG icon
28
Alphabet (Google) Class C
GOOG
$4.19T
$3.11M 1.13%
23,320
-6,680
-22% -$921K
CEVA icon
29
CEVA Inc
CEVA
$857M
$3.03M 1.1%
71,060
-5,180
-7% -$235K
META icon
30
Meta Platforms (Facebook)
META
$1.47T
$3.01M 1.09%
8,873
-2,927
-25% -$1.05M
ARCT icon
31
Arcturus Therapeutics
ARCT
$216M
$2.68M 0.98%
56,155
+5,155
+10% +$231K
DTIL icon
32
Precision BioSciences
DTIL
$205M
$2.68M 0.97%
7,733
+700
+10% +$237K
LTRX icon
33
Lantronix
LTRX
$275M
$2.37M 0.86%
406,879
USX
34
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
$2.24M 0.82%
260,000
+41,000
+19% +$356K
AERI
35
DELISTED
Aerie Pharmaceuticals
AERI
$2.2M 0.8%
193,266
+64,166
+50% +$938K
CELC icon
36
Celcuity
CELC
$4.49B
$2.19M 0.8%
121,832
+8,000
+7% +$170K
SRAX
37
DELISTED
SRAX, Inc. Class A Common Stock
SRAX
$1.97M 0.72%
368,541
-30,000
-8% -$144K
STRR
38
Star Equity Holdings
STRR
$40.1M
$1.83M 0.66%
114,907
+18,000
+19% +$314K
USIO icon
39
Usio Inc
USIO
$65.7M
$1.78M 0.65%
300,000
+20,000
+7% +$117K
CFRX
40
DELISTED
ContraFect Corporation
CFRX
$1.66M 0.6%
5,125
NET icon
41
Cloudflare
NET
$111B
$1.65M 0.6%
14,608
+608
+4% +$72.6K
TRAK icon
42
ReposiTrak
TRAK
$152M
$1.63M 0.59%
298,958
+70,000
+31% +$380K
DMTK
43
DELISTED
DermTech, Inc. Common Stock
DMTK
$1.62M 0.59%
50,415
+30,415
+152% +$1.07M
TELA icon
44
TELA Bio
TELA
$32.3M
$1.54M 0.56%
113,000
+10,000
+10% +$140K
CTSO icon
45
Cytosorbents Corp
CTSO
$23.3M
$1.5M 0.55%
185,000
NBSE
46
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$1.47M 0.53%
20,375
+3,100
+18% +$237K
ABUS icon
47
Arbutus Biopharma
ABUS
$908M
$1.46M 0.53%
340,000
INBK icon
48
First Internet Bancorp
INBK
$255M
$1.42M 0.51%
45,378
IDYA icon
49
IDEAYA Biosciences
IDYA
$3.56B
$1.39M 0.51%
54,575
+2,875
+6% +$67.1K
KRYS icon
50
Krystal Biotech
KRYS
$9.85B
$1.31M 0.48%
25,044
+8,144
+48% +$482K

Similar funds

Jacob Asset Management of New York's Q3 2021 Portfolio in Review

As of Q3 2021, Jacob Asset Management of New York held 85 positions worth $275M, down 9.2% from $303M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Jacob Asset Management of New York withdrew a net $14.8M in Q3 2021, closing 6 positions and reducing 26 holdings. Its most notable exit was SharpSpring, Inc., an estimated $10.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 35% a quarter earlier, followed by Healthcare and Communication Services.

Against the trend, Jacob Asset Management of New York opened a new position in Twist Bioscience worth $379K.

  • Jacob Asset Management of New York's largest Q3 2021 buy was Twist Bioscience: 3,543 shares worth $379K.
  • Jacob Asset Management of New York added most to Identive in Q3 2021, an estimated $2.38M increase.
  • Jacob Asset Management of New York's biggest Q3 2021 reduction was Tabula Rasa HealthCare, Inc. Common Stock, cutting an estimated $3.25M.
  • Jacob Asset Management of New York fully exited SharpSpring, Inc. in Q3 2021, selling an estimated $10.6M.
  • Jacob Asset Management of New York's ten largest holdings make up 44% of its $275M portfolio in Q3 2021.
  • Jacob Asset Management of New York opened 3 new positions and closed 6 in Q3 2021.
  • Jacob Asset Management of New York's portfolio value fell 9.2% quarter-over-quarter to $275M.

Based on Jacob Asset Management of New York's 13F filing for Q3 2021, filed 12 Nov 2021.